Table 1 Selected countries AMR National Surveillance Programs

Population^a

163.05 million

211.05 million

1.37 billion

6.86 million

31.95 million

58.56 million

41.98 million

World bank country classification by income[66]

LMIC

UMIC

LMIC

UMIC

UMIC

UMIC

LMIC

GLASS-AMR^a

Yes

Yes

Yes

Yes

Yes

yes

No

National action plan^a

In place

In place

In place

In place

In place

In place

Developed^b

National coordinating center^a

Established

Established

Established

Established

Established

Established

Number of enrolled national surveillance centers^a

8

18

130

30

110

353

 Number of enrolled hospitals

0

11

65

30

42

350

 In patient/outpatient facilities

8 Inpatient/ Outpatient facilities

7 outpatient facilities

65 outpatient facilities

0

68 outpatient facilities

3 outpatient facilities

Tertiary care hospitals^b

AST Standard^a

CLSI

EUCAST/CLSI

CLSI

EUCAST/CLSI

EUCAST/CLSI

EUCAST/CLSI

EUCAST^b

National Reference Laboratory^a

Established

Established

Established

Established

Established

Established

In progress^b

EQA

Provided

Provided

Not provided

Not reported

Provided

Provided

Provided^b

Number of laboratories performing AST^a

8

11

41

30

43

50

5^b

 AST provided for GLASS pathogens

Some pathogens

Some pathogens

Some pathogens

All pathogens

All pathogens

All pathogens for CAESAR^b

 EQA provided for bacterial identification^a

Some labs

Not provided

All labs

Some labs

All labs

All labs

All labs^b